Blood lipids, infection, and inflammatory markers in the Tsimane of Bolivia

American Journal of Human Biology

Volumn 22, Issue 6, 2010, Pages 731-740

  Vasunilashorn, Sarinnapha ^a   Crimmins, Eileen M ^a   Kim, Jung Ki ^a   Winking, Jeff ^b   Gurven, Michael ^c   Kaplan, Hillard ^d   Finch, Caleb E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LIPID;

ADULT; AGED; AMERICAN INDIAN; ARTICLE; BLOOD; BOLIVIA; ETHNOLOGY; FEMALE; HEALTH SURVEY; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; MORPHOMETRICS; PARASITOSIS; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BODY WEIGHTS AND MEASURES; BOLIVIA; FEMALE; HEALTH SURVEYS; HUMANS; INDIANS, SOUTH AMERICAN; INFLAMMATION; LIPIDS; MALE; MIDDLE AGED; PARASITIC DISEASES; SEX FACTORS;

EID: 79952200455     PISSN: 10420533     EISSN: 15206300     Source Type: Journal    
DOI: 10.1002/ajhb.21074     Document Type: Article

References (104)

1. Ahn YI, Valdez R, Reddy AP, Cole SA, Weiss KM, Ferrell RE. 1991. DNA polymorphisms of the apolipoprotein AI/CIII/AIV gene cluster influence plasma cholesterol and triglyceride levels in the Mayans of the Yucatan Peninsula, Mexico. Hum Hered 41: 281-289.
2. Alley DE, Seeman TE, Kim JK, Karlamangla A, Hu P, Crimmins EM. 2006. Socioeconomic status and C-reactive protein levels in the US population: NHANES IV. Brain Behav Immun 20: 495-504.
3. Alving CR, Wassef NM. 1999. Naturally occurring antibodies to cholesterol: a new theory of LDL cholesterol metabolism. Immunol Today 20: 362-366.
4. Anastos K, Lu D, Shi Q, Tien PC, Kaplan RC, Hessol NA, Cole S, Vigen C, Cohen M, Young M, Justman J. 2007. Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens. J Acquir Immune Defic Syndr 45: 34-42.
5. Assman G, Schulte H. 1987. The Prospective Cardiovascular Munster Study prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension. Am J Cardiol 59: 9-17.
6. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. 2002. Association of kidney function with anemia. Arch Intern Med 162: 1401-1408.
7. Au YPT, Schilling RF. 1986. Relationship between anemia and cholesterol metabolism in 'sex-linked anemic' (gene symbol, sla) mouse. Biochim Biophys Acta 883: 242-246.
8. Bansal D, Bhatti HS, Seghal R. 2005. Altered lipid parameters in patients infected with Entamoeba histolytica, Entamoeba dispar and Giardia lamblia. Br J Biomed Sci 62: 63-65.
9. Barbee RA, Halonen M, Lebowitz M, Burrows B. 1981. Distribution of IgE in a community population sample: correlations with age, sex, and allergen skin test reactivity. J Allergy Clin Immunol 68: 106-111.
10. Baruzzi RG. 1970. Contribution to the study of toxoplasmosis epidemiology. Serologic survey among the Indians of the Upper Xingu River, central Brazil. Rev Inst Med Trop Sao Paulo 12: 93-104.
11. Benefice E, Barral H. 1991. Differences in life style and nutritional status between settler and Siona-Secoya Indians living in the same Amazonian Milieu. Ecol Food Nutr 25: 1-16.
12. Berns MAM, de Vries JHM, Katan MB. 1989. Increase in body fatness as a major determinant of changes in serum total cholesterol and high density lipoprotein cholesterol in young men over a 10-year period. Am J Epidemiol 130: 1109-1122.
13. Byron EM. 2003. Market integration and health: the impact of markets and acculturation on the self-perceived morbidity, diet, and nutritional status of the Tsimane' Amerindians of lowland Bolivia. University of Florida, Ph.D. Dissertation.
14. Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, Grundy SM, Johnson CL. 2005. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 294: 1773-1781.
15. Caspar-Bauguil S, Tcaczuk J, Haure MJ, Durand M, Alcouffe J, Thomsen M, Salvayre R, Benosit H. 1999. Mildly oxidized low density lipoproteins decrease early production of interleukin-2 and nuclear factor kB binding to DNA in activated T-lymphocytes. Biochem J 337: 269-274.
16. Centers for Disease Control and Prevention. 1998. Pediatric nutrition surveillance, 1997 full report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
17. Chernela JM, Thatcher WE. 1989. Comparison of parasite burdens in two native Amazonian populations. Med Anthropol 10: 279-285.
18. Clarke R, Frost C, Collins R, Appleby R, Peto R. 1997. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ 11: 112-117.
19. Conner WE, Cerqueira MT, Connor RW, Wallace RB, Malinow MR, Casdorph HR. 1978. The plasma lipids, lipoproteins, and diet of Tarahumara Indians of Mexico. Am J Clin Nutr 31: 1131-1142.
20. Constans J, Pellegrin JL, Peuchant E, Dumon MF, Pellegrin I, Sergeant C, Simonoff M, Brossard G, Barbeau P, Fleury H, Cler M, Leng B, Conri C. Plasma lipids in HIV-infected patients: a prospectgive study in 95 patients. Eur J Clin Invest 24: 416-420.
21. Crimmins E, Vasunilashorn S, Kim JK, Alley D. 2008a. Biomarkers related to aging in human populations. Adv Clin Chem 46: 161-216.
22. Crimmins EM, Vasunilashorn S, Kim JK, Hagedorn A, Saito Y. 2008b. A comparison of biological risk factors in two populations: the United States and Japan. Popul Dev Rev 34: 457-482.
23. Crimmins EM, Finch CE. 2006a. Commentary: do older men and women gain equally from improving childhood conditions? Int J Epidemiol 35: 1270-1271.
24. Crimmins EM, Finch CE. 2006b. Infection, inflammation, height, and longevity. Proc Natl Acad Sci USA 103: 498-495.
25. Danesh J, Collins R, Appleby P, Peto T. 1998. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA 279:1477-1482.
26. Dahlen G, Ericson C, de Faire U, Iselius L, Lundman T. 1983. Genetic and environmental determinants of cholesterol and HDL-cholesterol concentrations in blood. Int J Epidemiol 12: 32-35.
27. DiaMed EuroGen. 2007. IgE Microtiterstrip ELISA kit. Turnhour, Belgium: DiaMed EuroGen.
28. Doenhoff MJ, Stanley RG, Griffiths K, Jackson CL. 2002. An anti-atherogenic effect of Schistoma mansoni infections in mice associated with a parasite-induced lowering of blood total cholesterol. Parasitology 125: 415-421.
29. Eaton SB, Konner M, Shostak M. 1988. Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective. Am J Med 84: 739-749.
30. Esteve E, Ricart W, Fernández-Real JM. 2005. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 24: 16-31.
31. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. 2001. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
32. Ferrucci L, Corsi A, Lauretani F, Bandinelli S, Bartali B, Taub DD, Guralnik JM, Longo DL. 2005. The origins of age-related proinflammatory state. Blood 105: 2294-2299.
33. Finch CE. 2007. The biology of human longevity. Burlington, MA: Elsevier. p 234-294.
34. Finch CE, Crimmins EM. 2004. Inflammatory exposure and historical changes in human life-spans. Science 305: 176-179.
35. Folcik VA, Aamir R, Cathcart MK. 1997. Cytokine modulation of LDL oxidation by activated human monocytes. Arterioscl Thromb Vasc Biol 17: 1954-1961.
36. Friedman GD, Klatsky AL, Siegelaub AB. 1974. The leukocyte count as a predictor of myocardial infarction. N Engl J Med 290: 1275-1278.
37. Gillum RF, Mussolino ME, Makuc DM. 1994. Erythrocyte sedimentation rate and coronary heart disease: the NHANES I epidemiologic follow-up study. J Clin Epidemiol 48: 353-361.
38. Godoy R, Nyberg C, Eisenberg DT, Magvanjav O, Shinnar E, Leonard WR, Gravlee C, Reyes-García V, McDade TW, Huanca T, Tanner S, Bolivian TAPS Study Team. 2009. Short but catching up: statural growth among native Amazonian Bolivian children. Am J Hum Biol 22: 336-347.
39. Grunfeld C, Pang M, Doerrler W, Sigenaga JK, Jensen P, Feingold KR. 1992. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 74: 1045-1052.
40. Gurven M, Kaplan H, Supa AZ. 2007. Mortality experience of Tsimane Amerindians of Bolivia: regional variation and temporal trends. Am J Hum Biol 19: 276-298.
41. Gurven M, Kaplan H, Winking J, Finch C, Crimmins EM. 2008. Aging and inflammation in two epidemiological worlds. J Gerontol A Biol Sci Med Sci 63: 196-199.
42. Gurven M, Kaplan H, Winking J, Rodriguez DE, Vasunilashorn S, Kim JK, Finch C, Crimmins E. 2009. Inflammation and infection do no promote arterial aging and cardiovascular disease among lean horticulturalists. PLoS One 4: e36590.
43. Hegele RA, Connelly PW, Hanley AJF, Sun F, Harris SB, Zinman B. 1997. Common genomic variants associated with variation in plasma lipoprotein in aboriginal Canadians. Arterioscler Thromb Vasc Biol 17: 1060-1066.
44. Heller DA, de Faire U, Pedersen NL, Dahlen G, McClearn GE. 1993. Genetic and environmental influences on serum lipid levels in twins. N Engl J Med 328: 1150-1156.
45. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, Renlund DG, Muhlestein JB, for the Intermountain Heart Collaborative (IHC) Study Group. 2005. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 45: 1638-1643.
46. Hsu C-Y, McCulloch CE, Curhan GC. 2002. Epedemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 13: 504-510.
47. Ingelsson E, Ärnlöv J, Sundström J, Lind L. 2005. Inflammation, as measured by erythrocyte sedimentation rate, is an independent predictor for the development of heart failure. J Am Coll Cardiol 45: 1802-1806.
48. Inouye M, Mio T, Sumino K. 1999. Glycated hemoglobin and lipid peroxidation in erythrocytes of diabetic patients. Metabolism 48: 205-209.
49. International Still's Disease Foundation website. Accessed January 21, 2008. Available: http://www.stillsdisease.org/lab_tests/cbc.
50. Jacobs DRJr, Hunninghake DB, Dempsey M, Taylor HL, Kuba K, Leupker RV, Dawson EA, Frantz IDJr, Hanna P. 1980. Blood lipids and lipoproteins in a Minnesota urban population. J Chron Dis 33: 395-406.
51. Jahangiri A, de Beer MC, Noffsinger V, Tannock LR, Ramaiah C, Webb NR, van der Westhuyzen DR, de Beer FC. 2009. HDL remodeling during the acute phase response. Arterioscler Throm Vasc Biol 29: 261-267.
52. Kannel WB, Vasan RS, Keyes MJ, Sullivan LM, Robins SJ. 2008. Usefulness of triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cariometabolic risk (from the Framingham Offspring Cohort). Am J Cardiol 101: 497-501.
53. Kaplan JE, Larrick JW, Yost J, Farrell L, Greenberg HB, Herrmann KL, Sulzer AJ, Walls KW, Pederson L. 1980. Infectious disease patterns in the Waorani, an isolated Amerindian population. Am J Trop Med Hyg 29: 298-312.
54. Kastarinen MJ, Nissinen AM, Vartiainen EA, Jousilahti PJ, Korhonen HJ, Puska PM. Tuomilehto JO. 2000. Blood pressure levels and obesity trends in hypertensive and normotensive Finnish population from 1982 to 1997. J Hypertens 18: 255-262.
55. Keys A, Fidanza F, Scardi V, Bergami G. 1952. The trend of serum cholesterol levels with age. Lancet 2: 209-210.
56. Khovidhunkit W, Kim M-S, Mmon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C. 2004. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45: 1169-1196.
57. Khovidhunkit W, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C. 2001. Cholesterol efflux by acute-phase high density lipoprotein: role of lecithin:cholesterol acyltransferase. J Lipid Res 42: 967-975.
58. Kitchens RL, Thompson PA. 2003. Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteins. J Endotoxin Res 9: 113-118.
59. Levels JHM, Pajkrt D, Schultz M, Hoek FJ, van Tol A, Meijers JCM, van Deventer SJH. 2007. Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsis. Biochim Biophys Acta 1771: 1429-1438.
60. Lindeberg S, Ahren B, Nilsson A, Cordain L, Nilsson-Ehle P, Vessby B. 2003. Determinants of serum triglycerides and high-density lipoprotein cholesterol in traditional Trobriand Islanders: the Kitava Study. Scand J Clin Lab Invest 63: 175-180.
61. Lymphomation website. Accessed January 21, 2008. Available: http://www.lymphomation.org/tests-immunoglobulins.htm#IgA.
62. Magen E, Borkow G, Bentwich Z, Mishal J, Scharf S. 2005. Can worms defend our hearts? Chronic helminthic infections may attenuate the development of cardiovascular diseases. Med Hypoth 64: 904-909.
63. Mahaney MC, Blangero J, Comuzzie AG, VandeBerg JL, Stern MP, MacCluer JW. 1995. Plasma HDL cholesterol, triglycerides, and adiposity: a quantitative genetic test of the Conjoint Trait Hypothesis in the San Antonio Family Heart Study. Circulation 92: 3240-3248.
64. Malik S, Wong ND, Franklin S, Pio J, Fairchild C, Chen R. 2005. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein. Diab Care 28: 690-693.
65. Mattson FH, Erikson BA, Kligman AM. 1972. Effect of dietary cholesterol on serum cholesterol in man. Am J Clin Nutr 25: 589-594.
66. Mazzarolo-Cruz HM, Cruz J, Milon DJr. 1995. Dyslipidaemias in white normotensive subjects and in white patients treated for essential hypertension. Rev Hosp Clin Fac Med Sao Paulo 50: 326-329.
67. McDade TW, Leonard WR, Burhop J, Reyes-GarciáVadez V, Huanca T, Godoy RA. 2005. Predictors of C-reactive protein in Tsimane' 2 to 15 year-olds in lowland Bolivia. Am J Phys Anthr 128: 906-913.
68. McDade TW, Reyes-Garcia V, Blackinton P, Tanner S, Huanca T, Leonard WR. 2007. Maternal ethnobotanical knowledge is associated with multiple measures of child health in the Bolivian Amazon. Proc Natl Acad Sci USA 104: 6134-6139.
69. McDade TW, Reyes-García V, Tanner S, Huanca T, Leonard WR. 2008. Maintenance versus growth: investigating the costs of immune activation among children in lowland Bolivia. Am J Phys Anthropol 136: 478-484.
70. McGullicuddy FC, de la Llera Moy M, Hinkle CC, Joshi MR, Chinquoine EH, Billheimer JT, Rothblat GH, Reilly MP. 2009. Inflammation impairs reverse cholesterol transport in vivo. Circulation 119: 1135-1145.
71. Medicine Net website. Accessed January 21, 2008. Available: http://www.medterms.com/script/main/art.asp?articlekey=15737.
72. Mendez J, Tejada C, Flores M. 1962. Serum lipid levels among rural Guatamalan Indians. Am J Clin Nutr 10: 403-409.
73. Miranda RA, Xavier FB, Menezes RC. 1998. Parasitismo intestinal em uma aldeia indígena Parakanã, sudeste do Estado do Pará, Brasil (Intestinal parasitism in a Parakanã indigenous community in southwestern Pará state, Brasil). Cadernos de Saúde Pública 14: 507-511.
74. Mitchell BD, Kammerer CM, Blangero J, Mahaney MC, Rainwater DL, Dyke B, Hixson JE, Henkel RD, Sharp M, Comuzzie AG, VandeBerg JL, Stern MP, MacCluer JW. Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Ciculation 94: 2159-2170.
75. Mjos OD, Thelle DS, Forde OH, Vik-Mo H. 1977. Family study of high density lipoprotein cholesterol and the relation to age and sex. The Tromso Heart Study. Acta Med Scand 201: 323-329.
76. North KE, Howard BV, Welty TK, Best LG, Lee ET, Yeh JL, Fabsitz RR, Roman MJ, MacCluer JW. 2003. Genetic and environmental contributions to cardiovascular disease risk in American Indians: the strong heart family study. Am J Epidemiol 157: 303-314.
77. O'Meara JG, Kardia SL, Armom JJ, Brown CA, Boerwinkle E, Turner ST. 2004. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Int Med 164: 1313-1318.
78. Oguntibeju OO. 2003. Parasitic infestation and anaemia: the prevalence in a rural hospital setting. J Indian Acad Clin Med 4: 210-212.
79. Pauletto P, Puato M, Caroli MG, Casiglia E, Munhambo AE, Cazzolato G, Bittolo Bon G, Angeli MT, Calli C, Pessina AC. 1996. Blood pressure and atherogenic lipoprotein profiles of fish-diet and vegetarian villagers in Tanzania: the Lugalawa study. Lancet 348: 784-788.
80. Pavan L, Casiglia E, Pauletto P, Batista SL, Ginocchio G, Kwankam MMY, Biasin R, Mazza A, Puato M, Russo E, Pessina AC. 1997. Blood pressure, serum cholesterol and nutritional state in Tanzania and in the Amazon: comparison with an Italian population. J Hypertens 15: 1083-1090.
81. Piva E, Sanzari MC, Servidio G, Plebani M. 2001. Length of sedimentation reaction in undiluted blood (erythrocyte sedimentation rate): variations with sex and age and reference limits. Clin Chem Lab Med 39: 451-454.
82. Rao DC, Laskarzewski PM, Morrison JA, Khoury P, Kelly K, Wette R, Russell J, Glueck CJ. 1982. The Cincinnati Lipid Research Clinic Family Study; Cultural and biological determinants of lipids and lipoprotein concentration. Am J Hum Genet 34: 888-903.
83. Reyes-Garcia V, Vadez V, Godoy R, Huanaca T, Leoanrd W, McDade T, Tanner S. 2008. Non-market returns to traditional and modern human capital: nutritional status in a native Amazonian society. J Dev Stud 44: 206-221.
84. Riddler SA, Li X, Chu H, Kingsley LA, Dobs A, Evans R, Palella F, Visscher B, Chmiel JS, Sharrett AR. 2007. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy. HIV Med 8: 280-287.
85. Ridker PM. 2003. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation 108: 81-85.
86. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJP, Koenig W, Libby P, Lorenzatti AJ, Macfadyen JG, Nordestgaard BG, Shephard J, Willerson JT, Glynn RJ, JUPITER Trial Study Group. 2009. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 4: 1175-1182.
87. Rimland D, Guest JL, Hernández-Ramos I, Del Rio C, Le NA, Brown WV. 2006. Antiretroviral therapy in HIV-positive women is associated with increased apolipoproteins and total cholesterol. J Acquir Immune Defic Syndr 42: 307-313.
88. Rose H, Woolley I, Hoy J, Dart A, Bryant B, Mijch A, Sviridov D. 2006. HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment. Metabolism 55: 90-95.
89. Santos RV, Coimbra CEA, Flowers NM, Silva JP. 1995. Intestinal parasitism in the Xavánte Indians, Central Brazil. Rev Inst Med Trop São Paulo 37: 145-148.
90. Seeman TE, Crimmins E, Huang M-H, Singer B, Bucur A, Gruenewald T, Berkman LF, Reuben DB. 2004. Cumulative biological risk and socioeconomic differences in mortality: MacArthur Studies of Successful Aging. Soc Sci & Med 58: 1985-1997.
91. Smith EM, Samadian S. 1994. Use of the erythrocyte sedimentation rate in the elderly. Br J Hosp Med 51: 394-397.
92. Sox HCJr, Liang MH. 1986. The erythrocyte sedimentation rate-guidelines for rational use. Ann Intern Med 104: 515-523.
93. Stern N, Grosskopf I, Shapira I, Kisch E, Isaacov A, Limor R, Baz M, Leshem Y, Flatau E, Miller A, Greenman Y. 2000. Risk factor clustering in hypertensive patients: impact of the reports of NCEP-II and second joint task force on coronary prevention on JNC-VI guidelines. J Int Med 248: 203-210.
94. Tanner SN. 2005. A population in transition: health, culture change, and intestinal parasitism among the Tsimane' of lowland Bolivia. University of Michigan, Ph.D. Dissertation.
95. Tanner S, Leonard WR, McDade TW, Reyes-Garcia V, Godoy R, Huanca T. 2009. Influence of helminth infections on childhood nutritional status in lowland Bolivia. Am J Hum Biol 21: 651-656.
96. Vadez V, Reyes-García V, Godoy RA, Apaza VL, Byron E, Huanca T, Leonard WR, Perez E, Wilkie D. 2004. Does integration to the market threaten agricultural diversity? Panel and cross-sectional data from a horticultural-foraging society in the Bolivian Amazon. Hum Ecol 32: 635-646.
97. Vasunilashorn S, Finch CE, Kim JK, Winking J, Gurven M, Kaplan H, Crimmins EM. 2010. Biomarkers of aging in two societies: The US and the Tsimane of Bolivia. Forthcoming.
98. Waldron I. 1983. Sex differences in human mortality: the role of genetic factors. Soc Sci Med 17: 321-333.
99. Walker RS, Gurven M, Burger O, Hamilton MJ. 2008. The trade-off between number and size of offspring in humans and other primates. Proc R Soc B. 275: 827-833.
100. Walter T, Olivares M, Pizarro F, Muñoz C. 1997. Iron, anemia, and infection. Nutr Rev 55: 111-124.
101. Werner GT, Sareen DK. 1978. Serum cholesterol levels in the population of Punjab in north west India. Am J Clin Nutr 31: 1479-1483.
102. Wiedermann U, Stemberger H, Unfried E, Widhalm K, Kundi M, Altenriederer M, Savedra M, Wiedermann G. 1991. Intestinal worm burden and serum cholesterol or lipid concentration in a Shipibo population (Peru). Zentralbl Bakteriol 275: 279-286.
103. Wilson PW, Anderson KM, Harris T, Kannel WB, Casteli WP. 1994. Determinants of change in total cholesterol and HDL-C with age: the Framingham study. J Gerontol A Biol Sci Med Sci 49: 252-257.
104. Zangerle R, Sarcletti M, Gallati H, Reibnegger G, Wachter H, Fuchs D. 1994. Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activation. J Acquir Immune Defic Syndr Hum Retrovirol 7: 1149-1156.